Disease | angina pectoris |
Phenotype | C0004153|atherosclerosis |
Sentences | 6 |
PubMedID- 21262005 | Background: coronary angiography is the current standard method to evaluate coronary atherosclerosis in patients with suspected angina pectoris, but non-invasive ct scanning of the coronaries are increasingly used for the same purpose. |
PubMedID- 26322175 | Several studies in human using anti-inflammatory agents and ras inhibitors revealed vascular benefits and reduced progression of coronary atherosclerosis in patients with stable angina pectoris; decreased vascular inflammatory markers, improved common carotid intima-media thickness and plaque volume in patients with diagnosed atherosclerosis. |
PubMedID- 22386701 | Relationship between myocardial bridges and reduced coronary atherosclerosis in patients with angina pectoris. |
PubMedID- 22238350 | Therefore, echocardiographic eat may become a predictor of subclinical atherosclerosis in patients with stable angina pectoris. |
PubMedID- 24832521 | One of the ligands for the ccr5 receptor, ccl5 or rantes, has also been shown to be involved in unstable angina pectoris, which usually results from atherosclerosis [10]. |
PubMedID- 21796255 | Several prospective, randomized studies show vascular benefits with olmesartan medoxomil: reduced progression of coronary atherosclerosis in patients with stable angina pectoris (olivus); decreased vascular inflammatory markers in patients with hypertension and micro- (pre-clinical) inflammation (eutopia); improved common carotid intima-media thickness and plaque volume in patients with diagnosed atherosclerosis (more); and resistance vessel remodeling in patients with stage 1 hypertension (vios). |
Page: 1